DENTSPLY Stock Is Likely To Offer Superior Returns Over This Pharmaceuticals Company

We think that DENTSPLY stock (NASDAQ: XRAY), a dental equipment company, is currently a better pick than Teva Pharmaceuticals stock (NYSE: TEVA), despite it being the more expensive of the two, trading at 2.0x trailing revenues compared to 0.5x for Teva.